Fenwick & West represented BILL Holdings, Inc. in the offering, and Wilson Sonsini Goodrich & Rosati represented the initial purchasers. BILL Holdings, Inc. (NYSE: BILL), a...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...
You must be a Standard 1 Year member to access this content.
